Solidion Technology (STI) is up more than 200% on Monday's session but has still sold off close to 50% since the start of the year. The stock's surging price action followed an unveiling of Solidion's next-gen A.I.
Labcorp launches self-collection options for HPV and STI testing in its PSCs.